IL17A and type 1 diabetes mellitus: Delayed onset of T1D, preserved islets, reduced insulitis and T cell infiltration, reduced APC and T cell activation, reduced Th1/Th17 population, reduced inflammatory cytokines (IL-17, IL-6, IFN-γ, TNF-a and IL-12) levels